8-K 1 v343092_8k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 26, 2013

 

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)

 

 

Delaware   001-32374   35-1996126

(State or other jurisdiction

of incorporation)

   (Commission File Number)  

(IRS Employer

Identification No.)

 

3724 N State Road 15, Warsaw, Indiana 46582

(Address of Principal executive offices, including Zip Code)

 

(574) 268-2252

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

 

Item 5.07 Submission of Matters of a Vote of Security Holders

 

The Annual Meeting of Shareholders of Symmetry Medical Inc. was held on Friday, April 26, 2013.  The Board of Directors fixed the close of business on March 4, 2013 as the record date for the determination of stockholders entitled to notice of and to vote at the Annual Meeting and at any adjournment thereof.  On this record date, there were outstanding and entitled to vote 37,294,465 shares of Common Stock. A total of 35,435,576, representing 95.01% of outstanding shares, were voted at the Annual Meeting. There were three issues proposed for vote by the stockholders:

 

Proposal 1- Election of Class II Directors. Voting for the Class II Directors elected to serve for a term of three years is summarized as follows:

 

Craig Reynolds: For 32,864,247
  Withheld 1,035,735
  Non Votes 1,535,594
     

James Burns:

 For 32,699,752
  Withheld 1,200,230
  Non Votes 1,535,594

 

Proposal 2 – Advisory vote regarding the Company’s executive compensation program. The results of the advisory vote are summarized as follows:

 

For 32,643,321
Against 725,840
Abstain 530,821
Non Votes 1,535,594

 

At the 2011 Annual Meeting of Shareholders the Company’s Shareholders voted in favor of the Company providing them with annual opportunities to provide advisory votes regarding the Company’s executive compensation program. The Board has adopted that proposal and will provide the Company’s Shareholders with annual opportunities to provide advisory votes regarding the executive compensation program in the future.

 

Proposal 3 – Ratification and Approval of the appointment of the firm of Ernst & Young LLP as independent auditors of the Company for Fiscal 2013. Voting on this proposal is summarized as follows:

 

For 34,043,447
Against 862,038
Abstain 530,091

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Symmetry Medical Inc.
   
  /s/ Fred L. Hite
Date: April 29, 2013 Name:    Fred L. Hite
  Title:      Chief Financial Officer